Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New inhibitors of insulin-like growth factor 1 receptor presented

Dec. 29, 2010

AKN-028 significantly alters gene expression profiles of AML cells

Dec. 29, 2010

PI3K-alpha inhibitor PIK-75 induces apoptosis of AML cells

Dec. 29, 2010

EMA to review Allos' MAA for Folotyn in relapsed or refractory PTCL

Dec. 28, 2010

Vertex Pharma patents new inhibitors of hepatocyte growth factor receptor

Dec. 28, 2010

New CREB-1 inhibitor XX-650-23 shows promise to treat AML

Dec. 28, 2010

Enrollment completed in phase II study of belinostat in carcinoma of unknown primary

Dec. 27, 2010

Novartis receives E.U. approval for Tasigna in newly diagnosed Ph+ CML

Dec. 27, 2010

Phase IIb study begins of Azixa as front-line treatment for glioblastoma multiforme

Dec. 27, 2010

Cyclacel's cell cycle inhibitor CYC-065 suppresses growth of MM cell in vitro

Dec. 27, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...